FDA Approved: REGADENOSON — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma Pharmaceuticals USA Inc. for Regadenoson (ANDA 215827) as a generic injectable pharmacologic stress agent for myocardial perfusion imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)